(ORE) Orezone Gold - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA68616T1093

ORE: Gold, Minerals

Orezone Gold Corporation is a Canadian gold mining and exploration company focused on advancing its flagship Bomboré gold project in Burkina Faso, West Africa. The company holds a 90% interest in the project, which is one of the largest undeveloped gold deposits in the region. Incorporated in 2008 and headquartered in Vancouver, Orezone has established itself as a key player in West Africas gold sector, with a strong emphasis on resource expansion and development. The Bomboré project boasts a measured and indicated resource of 2.58 million ounces of gold, positioning it as a critical asset for the companys growth strategy. Orezone is also exploring additional gold prospects in Burkina Faso, further diversifying its portfolio.

From a technical standpoint, Orezones stock (TO:ORE) is currently trading at CAD 0.83, aligning with its 20-day simple moving average (SMA). The stock has shown stability, with a 50-day SMA of 0.73 and a 200-day SMA of 0.72, indicating a slight upward trend. The average true range (ATR) of 0.04 reflects low volatility, suggesting manageable risk for investors. On the fundamental side, Orezones market capitalization stands at CAD 419.08 million, with a price-to-earnings (P/E) ratio of 9.00 and a forward P/E of 3.32, signaling potential undervaluation. The price-to-book (P/B) ratio of 1.30 and price-to-sales (P/S) ratio of 1.62 further highlight the companys valuation metrics. With a return on equity (RoE) of 13.06%, Orezone demonstrates solid profitability relative to its equity.

Based on and , Orezone Gold Corporation (TO:ORE) is expected to maintain its current trading range over the next three months. The stocks alignment with its 20-day SMA, coupled with its low ATR, suggests continued stability. However, the forward P/E of 3.32 and the companys resource expansion plans at Bomboré could drive upward momentum, potentially pushing the stock above CAD 0.85 by the end of the quarter. Investors should monitor the companys progress in advancing its gold projects and any updates on production timelines, as these factors could significantly impact the stocks performance.

Additional Sources for ORE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ORE Stock Overview

Market Cap in USD 300m
Sector Basic Materials
Industry Gold
GiC Sub-Industry Gold
IPO / Inception

ORE Stock Ratings

Growth Rating -10.9
Fundamental 45.1
Dividend Rating 0.0
Rel. Strength 68.7
Analysts -
Fair Price Momentum 1.34 CAD
Fair Price DCF 0.35 CAD

ORE Dividends

No Dividends Paid

ORE Growth Ratios

Growth Correlation 3m 72.4%
Growth Correlation 12m 23.1%
Growth Correlation 5y -81.8%
CAGR 5y 1.42%
CAGR/Max DD 5y 0.02
Sharpe Ratio 12m -0.06
Alpha 51.96
Beta 2.204
Volatility 83.25%
Current Volume 2162.4k
Average Volume 20d 676.2k
What is the price of ORE stocks?
As of April 19, 2025, the stock is trading at CAD 1.31 with a total of 2,162,400 shares traded.
Over the past week, the price has changed by +20.18%, over one month by +33.67%, over three months by +89.86% and over the past year by +55.95%.
Is Orezone Gold a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Orezone Gold (TO:ORE) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 45.12 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ORE as of April 2025 is 1.34. This means that ORE is currently overvalued and has a potential downside of 2.29%.
Is ORE a buy, sell or hold?
Orezone Gold has no consensus analysts rating.
What are the forecast for ORE stock price target?
According to ValueRays Forecast Model, ORE Orezone Gold will be worth about 1.5 in April 2026. The stock is currently trading at 1.31. This means that the stock has a potential upside of +15.27%.
Issuer Forecast Upside
Wallstreet Target Price 1.6 21.4%
Analysts Target Price - -
ValueRay Target Price 1.5 15.3%